Archer Materials announced miniaturization of its Biochip graphene field effect transistor design

Archer Materials has announced that successfully miniaturized its Biochip graphene field effect transistor (gFET) design, reducing its size by 97% and significantly lowering fabrication costs. The development marks a significant step in Archer’s efforts to strengthen its semiconductor capabilities and expand its role in medical diagnostics.

This advancement, achieved in collaboration with Applied Nanolayers and AOI Electronics, enhances the chip’s readiness for integration in home testing devices for chronic kidney disease. 

In March 2024, Archer Materials announced that it designed a miniaturized version of its Biochip graphene field effect transistor ("gFET") chip for fabrication at a commercial foundry.